Issued 2026-09-16 at $305.63 · now $305.63 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, HLT has typically landed between $273.71 and $341.46 — a range of −10.4% to +11.7% from the issuance price $305.63.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
3,187 overlapping 1 month windows · 2013-12-12 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($305.63) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where HLT has typically landed a month from the 2026-09-16 close of $305.63 — the range is history, not a prediction.
- now $305.63 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $311.87 (+2.0%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $298.13–$325.6
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $273.71–$341.46
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2020-02-18 | −49.3% | −49.3% | +0.7% |
| 2020-02-19 | −48.4% | −49.6% | +0.0% |
| 2020-02-20 | −44.9% | −49.3% | +0.0% |
| 3 best | |||
| 2020-03-18 | +33.4% | −1.3% | +33.4% |
| 2020-04-03 | +28.2% | +0.0% | +41.7% |
| 2016-02-03 | +25.7% | +0.0% | +25.7% |
3,187 overlapping windows · 2013-12-12 – 2026-09-16 · not cherry-picked
Fundamentals iCompany financials — revenue, earnings, margins — from the newest filings shown, each carried with its date.iAs-reported figures and standard ratios from FMP, as of 2026-07-25. Revenue, net income and free cash flow can toggle annual or quarterly; margin, ROE and debt-to-equity are shown by fiscal year. We report the figures and the trend — no target price and no over/under-valued call. More on /methodology.
Fair value — three views iIndependent reference estimates of worth (a cash-flow model, peer multiples, analyst targets), shown as separate views — not a single verdict.
iThree independent estimates of per-share value, each by a different method and each with its own assumptions: a discounted-cash-flow intrinsic value, a peer comparable (the median trailing P/E of 50 sector peers times this company's trailing EPS), and the analyst price-target consensus. They routinely disagree — that gap is the point. We show the three marks and the current price; we do not blend them into a single number or call the stock over- or under-valued. Marks as of the latest capture. More on /methodology.- DCF (intrinsic)$130.68
- Peer P/E × EPS · sector median 23.8× · n=50$156.03
- Analyst target · range $312.00–$379.00$344.50
- Current price · last close 2026-09-16$305.63
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~13 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 | Fuentes Laura | director | Sale | 4,396 @ $309.80 | $1.4M | −10.8% of holding | not yet — horizon still open | not yet — horizon still open | 36,351 | Form 4 · filed 1 day after the trade |
| 2026-09-14 | Fuentes Laura | director | Sale | 2,893 @ $309.82 | $896K | −8.0% of holding | not yet — horizon still open | not yet — horizon still open | 33,458 | Form 4 · filed 1 day after the trade |
| 2026-09-14 | Carr Chris | director | Sale | 439 @ $310.34 | $136K | −5.1% of holding | not yet — horizon still open | not yet — horizon still open | 8,252 | Form 4 · filed 1 day after the trade |
| 2026-02-17 | NASSETTA CHRISTOPHER J | director | Sale | 47,134 @ $317.36 | $15.0M | −39.2% of holding | −4.1% | −9.8% | 73,196 | Form 4 · filed 2 days after the trade |
| 2026-02-17 | NASSETTA CHRISTOPHER J | director | Sale | 30,404 @ $316.27 | $9.6M | −20.2% of holding | −4.1% | −9.8% | 120,330 | Form 4 · filed 2 days after the trade |
| 2026-02-17 | NASSETTA CHRISTOPHER J | director | Sale | 27,376 @ $318.37 | $8.7M | −37.4% of holding | −4.1% | −9.8% | 45,820 | Form 4 · filed 2 days after the trade |
| 2026-02-17 | NASSETTA CHRISTOPHER J | director | Sale | 9,375 @ $319.30 | $3.0M | −20.5% of holding | −4.1% | −9.8% | 36,445 | Form 4 · filed 2 days after the trade |
| 2025-08-21 | Silcock Christopher W | officer | Sale | 11,905 @ $269.40 | $3.2M | −13.0% of holding | −6.1% | +8.0% | 79,451 | Form 4 · filed 1 day after the trade |
| 2025-02-07 | NASSETTA CHRISTOPHER J | director | Sale | 40,653 @ $268.83 | $10.9M | −34.4% of holding | −6.5% | −9.6% | 77,383 | Form 4 · filed same day |
| 2025-02-07 | Silcock Christopher W | officer | Sale | 2,914 @ $269.54 | $785K | −4.0% of holding | −6.5% | −9.6% | 70,453 | Form 4 · filed 3 days after the trade |
| 2024-12-16 | Duffy Michael W | officer | Sale | 23,366 @ $251.66 | $5.9M | −50.6% of holding | −1.3% | −0.4% | 22,833 | Form 4 · filed 1 day after the trade |
| 2024-02-07 | Mabus Raymond E | director | Purchase | 53 @ $197.39 | $10K | +0.4% of holding | +2.3% | −2.5% | 14,449 | Form 4 · filed 510 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
148 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-14 | Fuentes Laura | director | Option exercise | 7,936 | 35,859 | Form 4 |
| 2026-09-14 | Fuentes Laura | director | Option exercise | 4,888 | 40,747 | Form 4 |
| 2026-09-14 | Fuentes Laura | director | Option exercise | 7,936 | 0 | Form 4 |
| 2026-09-14 | Fuentes Laura | director | Option exercise | 4,888 | 0 | Form 4 |
| 2026-08-05 | Charnaux Christian H. | director | Withheld for tax | 1,854 | 16,435 | Form 4 |
| 2026-06-30 | Carr Chris | director | Award / grant | 3 | 8,691 | Form 4 |
| 2026-06-30 | Healey Melanie | director | Award / grant | 6 | 16,678 | Form 4 |
| 2026-06-30 | GRAY JONATHAN | director | Award / grant | 4 | 9,294 | Form 4 |
| 2026-06-30 | SMITH ELIZABETH A | director | Award / grant | 8 | 23,325 | Form 4 |
| 2026-06-30 | STEENLAND DOUGLAS M | director | Award / grant | 9 | 29,176 | Form 4 |
| 2026-06-30 | Mabus Raymond E | director | Award / grant | 5 | 15,223 | Form 4 |
| 2026-06-30 | MAYER MARISSA A | director | Award / grant | 1 | 1,788 | Form 4 |
| 2026-06-30 | BEGLEY CHARLENE T | director | Award / grant | 6 | 15,445 | Form 4 |
| 2026-05-14 | BEGLEY CHARLENE T | director | Award / grant | 742 | 15,440 | Form 4 |
| 2026-05-14 | Carr Chris | director | Award / grant | 742 | 8,688 | Form 4 |
| 2026-05-14 | STEENLAND DOUGLAS M | director | Award / grant | 742 | 29,167 | Form 4 |
| 2026-05-14 | GRAY JONATHAN | director | Award / grant | 742 | 9,290 | Form 4 |
| 2026-05-14 | Mabus Raymond E | director | Award / grant | 742 | 15,218 | Form 4 |
| 2026-05-14 | MAYER MARISSA A | director | Award / grant | 742 | 1,787 | Form 4 |
| 2026-05-14 | SMITH ELIZABETH A | director | Award / grant | 742 | 23,317 | Form 4 |
| 2026-05-14 | Healey Melanie | director | Award / grant | 742 | 16,672 | Form 4 |
| 2026-05-01 | MAYER MARISSA A | director | Award / grant | 115 | 1,045 | Form 4 |
| 2026-05-01 | GRAY JONATHAN | director | Award / grant | 104 | 8,548 | Form 4 |
| 2026-05-01 | SMITH ELIZABETH A | director | Award / grant | 145 | 22,575 | Form 4 |
| 2026-04-03 | Krass Caroline | officer | Withheld for tax | 778 | 4,556 | Form 4 |
| 2026-03-31 | GRAY JONATHAN | director | Award / grant | 4 | 8,444 | Form 4 |
| 2026-03-31 | Healey Melanie | director | Award / grant | 7 | 15,930 | Form 4 |
| 2026-03-31 | SMITH ELIZABETH A | director | Award / grant | 9 | 22,430 | Form 4 |
| 2026-03-31 | STEENLAND DOUGLAS M | director | Award / grant | 9 | 28,425 | Form 4 |
| 2026-03-31 | Carr Chris | director | Award / grant | 3 | 7,946 | Form 4 |
| 2026-03-31 | Mabus Raymond E | director | Award / grant | 6 | 14,476 | Form 4 |
| 2026-03-31 | MAYER MARISSA A | director | Award / grant | 0 | 930 | Form 4 |
| 2026-03-31 | BEGLEY CHARLENE T | director | Award / grant | 7 | 14,698 | Form 4 |
| 2026-03-03 | NASSETTA CHRISTOPHER J | director | Withheld for tax | 50,678 | 91,612 | Form 4 |
| 2026-03-03 | Jacobs Kevin J | director | Withheld for tax | 16,414 | 274,145 | Form 4 |
| 2026-03-03 | Silcock Christopher W | officer | Withheld for tax | 8,764 | 88,257 | Form 4 |
| 2026-03-03 | Fuentes Laura | director | Withheld for tax | 5,212 | 27,923 | Form 4 |
| 2026-03-03 | Moylan Misha | officer | Withheld for tax | 204 | 3,883 | Form 4 |
| 2026-02-25 | Charnaux Christian H. | director | Award / grant | 2,229 | 18,289 | Form 4 |
| 2026-02-25 | Charnaux Christian H. | director | Award / grant | 6,169 | 6,169 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures iStock trades disclosed by members of Congress for this company, by the date they were filed.iDisclosures shown as facts. A purchase “cluster” (≥2 members of Congress filing a buy within 90 days) has historically preceded modestly higher forward returns — and it persisted out-of-sample, though it roughly halved after 2021 (see below). A descriptive historical tendency, not a signal to trade and not used in our forecast. See /methodology.
As of 2026-09-16 · point-in-time by filed date
A cluster = ≥2 members of Congress filing a purchase within 90 days. The historical tilt persisted after 2021 but roughly halved (+45 → +32 bp/mo forward 1-month vs the S&P 500 weekly-grid baseline). Descriptive historical tendency — not a signal to trade, and not used in our forecast (audition-log 2026-07-27, recomputed 2026-09-08).
| Member | Chamber | Type | Filed | Traded | Size |
|---|---|---|---|---|---|
| Alan Armstrong | Senate | purchase | 2026-07-21 | 2026-03-27 | $1–15K |
| Jonathan Jackson | House | purchase | 2026-07-15 | 2026-06-15 | $1–15K |
| Ro Khanna | House | sale | 2026-07-06 | 2026-06-30 | $1–15K |
| Ro Khanna | House | purchase | 2026-06-09 | 2026-05-27 | $1–15K |
| Ro Khanna | House | purchase | 2026-04-07 | 2026-03-30 | $1–15K |
| Michael T. McCaul | House | sale | 2026-03-10 | 2026-02-06 | $1–15K |
| Michael T. McCaul | House | sale | 2026-03-10 | 2026-02-23 | $15–50K |
| Ro Khanna | House | purchase | 2026-02-06 | 2026-01-29 | $1–15K |
| Ro Khanna | House | purchase | 2026-02-06 | 2026-01-23 | $1–15K |
| Markwayne Mullin | Senate | purchase | 2026-01-16 | 2025-12-29 | $15–50K |
| Ro Khanna | House | sale | 2025-12-08 | 2025-11-03 | $1–15K |
| Michael T. McCaul | House | sale | 2025-11-10 | 2025-10-27 | $1–15K |
| Valerie Hoyle | House | sale | 2025-10-10 | 2025-09-23 | $1–15K |
| Michael T. McCaul | House | exchange | 2025-09-25 | 2024-03-25 | $100–250K |
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.